-transparent.png){kind=logo}
During liver fibrogenesis, Ito cells are regarded as the principal matrix synthesizing cells and transforming growth factor beta 1 (TGF-beta 1) appears to be the main fibrogenic mediator. This study analyzed the effects of TGF-beta 1 on Ito cell activation, proliferation, and on the expression of a set of matrix proteins, antiproteases, and TGF-beta receptors both in "early cultured" and "culture-activated" Ito cells. Rat liver Ito cells at day 2 of primary culture ("early cultured" cells) were mainly smooth muscle alpha actin (SMA)-negative, whereas cells at day 6 were judged as "activated" cells (SMA-positive). Following 24-hour exposure to 1 ng/mL TGF-beta 1, total protein synthesis, cell proliferation, and expression of the "activation" marker SMA were not significantly changed. In addition to previously described stimulatory effects on collagen types I and III, fibronectin, undulin, and proteoglycan-gene expression, TGF-beta also dose-dependently increased synthesis and secretion of tenascin, laminin, entactin, collagen type IV, and alpha 2-macroglobulin, but decreased C1-esterase inhibitor production by Ito cells, as revealed by immunoprecipitation of endogenously labeled proteins and by Northern blot analysis. The stimulatory effect of TGF-beta was evident both in "early cultured" as well as "culture-activated" Ito cells. By reverse-transcription polymerase chain reaction (RT-PCR) analysis, TGF-beta type II, III, and TGF-beta/activin type I receptors were present in Ito cells, and their expression pattern was not changed upon TGF-beta exposure. Northern blot analysis demonstrated that type I TGF-beta/activin receptor was induced during in vitro activation and that TGF-beta exposure resulted in a slight increase of type I and III receptor messenger RNAs. In summary, the data illustrate that TGF-beta is an important fibrogenic mediator acting both on "early cultured" as well as "culture-activated" Ito cells, rather than a mitogenic or morphogenic mediator. The differential regulation of TGF-beta/activin receptors during in vitro activation and their up-regulation by TGF-beta 1 might represent a mechanism by which the receptor complex regulates TGF-beta signalling in Ito cells.
T Knittel, and
T Janneck, and
L Müller, and
P Fellmer, and
G Ramadori
July 1992,
The Journal of biological chemistry,
T Knittel, and
T Janneck, and
L Müller, and
P Fellmer, and
G Ramadori
April 1995,
Cancer research,
T Knittel, and
T Janneck, and
L Müller, and
P Fellmer, and
G Ramadori
October 1994,
Hepatology (Baltimore, Md.),
T Knittel, and
T Janneck, and
L Müller, and
P Fellmer, and
G Ramadori
November 1990,
Molecular and cellular biology,
T Knittel, and
T Janneck, and
L Müller, and
P Fellmer, and
G Ramadori
January 1992,
Molecular immunology,
T Knittel, and
T Janneck, and
L Müller, and
P Fellmer, and
G Ramadori
November 1989,
The Journal of cell biology,
T Knittel, and
T Janneck, and
L Müller, and
P Fellmer, and
G Ramadori
March 1994,
Thorax,
T Knittel, and
T Janneck, and
L Müller, and
P Fellmer, and
G Ramadori
April 1998,
British journal of cancer,
T Knittel, and
T Janneck, and
L Müller, and
P Fellmer, and
G Ramadori
October 1993,
Laboratory investigation; a journal of technical methods and pathology,
T Knittel, and
T Janneck, and
L Müller, and
P Fellmer, and
G Ramadori
June 2006,
Kidney international,
